Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:10 pm Sale |
2024-12-31 | 13G | PaxMedica, Inc. Common Stock PXMD |
Lind Global Fund II LP | 985,000 9.900% |
-23,599 (-2.34%) |
Filing History |
| 2024-11-14 7:22 pm Purchase |
2024-09-30 | 13G | PaxMedica, Inc. Common Stock PXMD |
Lind Global Fund II LP | 1,008,599 8.800% |
756,829 (+300.60%) |
Filing History |
| 2024-02-13 8:11 pm Purchase |
2023-12-31 | 13G | PaxMedica, Inc. Common Stock PXMD |
Lind Global Fund II LP | 251,770 9.900% |
251,770 (New Position) |
Filing History |
| 2023-11-29 4:33 pm Purchase |
2023-11-22 | 13G | PaxMedica, Inc. Common Stock PXMD |
Lind Global Fund II LP | 450,000 9.900% |
450,000 (New Position) |
Filing History |
| 2022-09-09 4:27 pm Purchase |
2022-08-25 | 13D | PaxMedica, Inc. Common Stock PXMD |
TardiMed Sciences LLC | 452,809 63.400% |
452,809 (New Position) |
Filing History |
| 2022-09-09 4:24 pm Purchase |
2022-08-25 | 13G | PaxMedica, Inc. Common Stock PXMD |
Blue Cane Partners LLC | 69,118 9.900% |
69,118 (New Position) |
Filing History |